Literature DB >> 29577987

Generalized pruritus relieved by NSAIDs in the setting of mast cell activation syndrome.

Katrina Kesterson1, Zachary Nahmias2, Jonathan R Brestoff3, Nancy D Bodet4, Andrew Kau5, Brian S Kim6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29577987      PMCID： PMC7251497          DOI： 10.1016/j.jaip.2018.03.002

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  7 in total

1.  Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.

Authors:  Peter Valent; Cem Akin; Michel Arock; Knut Brockow; Joseph H Butterfield; Melody C Carter; Mariana Castells; Luis Escribano; Karin Hartmann; Philip Lieberman; Boguslaw Nedoszytko; Alberto Orfao; Lawrence B Schwartz; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Rudolf Valenta; Hans-Peter Horny; Dean D Metcalfe
Journal:  Int Arch Allergy Immunol       Date:  2011-10-27       Impact factor: 2.749

2.  Mast cell activation syndrome: Proposed diagnostic criteria.

Authors:  Cem Akin; Peter Valent; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2010-10-28       Impact factor: 10.793

Review 3.  Mast cell activation syndromes.

Authors:  Cem Akin
Journal:  J Allergy Clin Immunol       Date:  2017-08       Impact factor: 10.793

Review 4.  Spectrum of mast cell activation disorders.

Authors:  Anastasia I Petra; Smaro Panagiotidou; Julia M Stewart; Pio Conti; Theoharis C Theoharides
Journal:  Expert Rev Clin Immunol       Date:  2014-05-01       Impact factor: 4.473

5.  Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.

Authors:  Anupama Ravi; Joseph Butterfield; Catherine R Weiler
Journal:  J Allergy Clin Immunol Pract       Date:  2014-11-06

6.  Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.

Authors:  Joseph H Butterfield; Catherine R Weiler
Journal:  Int Arch Allergy Immunol       Date:  2008-07-12       Impact factor: 2.749

7.  Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans.

Authors:  T E Liston; L J Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205
  7 in total
  1 in total

Review 1.  The Return of the Mast Cell: New Roles in Neuroimmune Itch Biology.

Authors:  Fang Wang; Ting-Lin B Yang; Brian S Kim
Journal:  J Invest Dermatol       Date:  2020-04-02       Impact factor: 8.551
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.